Lambert-Eaton Myasthenic Syndrome

This is a rare nerve disorder that causes muscle weakness, especially in the legs and arms. It makes it hard to walk or climb stairs. It's caused by a problem with nerves sending signals to muscles.

Condition

What people with Lambert-Eaton Myasthenic Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Mestinon (Pyridostigmine) for Lambert-Eaton Myasthenic Syndrome?

NameHow it went

About Lambert-Eaton Myasthenic Syndrome

What It Is

Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune condition in which the immune system interferes with the signal that tells muscles to contract. The result is weakness and easy tiring that usually starts in the hips and thighs, making it hard to climb stairs, rise from a chair or walk any distance. Weakness often spreads over weeks to months to the shoulders and arms, and sometimes affects the eyelids, speech or swallowing, though usually only mildly. LEMS also affects the automatic nervous system that controls glands and blood vessels. Dry mouth is very common, and some people notice dry eyes, constipation, lightheadedness on standing or erectile problems. Reflexes such as the knee jerk are usually reduced or absent. LEMS is often mistaken for myasthenia gravis, a better-known condition that also weakens muscles. The differences help doctors tell them apart: LEMS tends to begin in the legs rather than the eyes, it reduces reflexes and causes dry mouth, and strength may briefly improve during a few seconds of effort rather than fading.

Causes & Risk Factors

In LEMS, antibodies attack calcium channels on the nerve endings that connect to muscles. These channels are needed to release acetylcholine, the chemical messenger that triggers a muscle to contract. With less acetylcholine released, nerve signals reach the muscle too weakly to produce full strength. About half of people with LEMS have an underlying small cell lung cancer. The cancer cells carry the same calcium channels, and the immune response aimed at the tumor also strikes the nerve endings. This form is more common in older adults, especially men with a long history of smoking, and LEMS symptoms often appear months or even a few years before the cancer can be found. In the other half, there is no cancer. This form can begin at any age, is more common in women, and often occurs alongside other autoimmune conditions such as thyroid disease. Why the immune system starts making these antibodies is not known.

How It's Diagnosed

Diagnosis starts with the pattern of symptoms and an examination looking for leg-predominant weakness, reduced reflexes and dry mouth. Two tests usually confirm it. A blood test looks for antibodies against the P/Q-type voltage-gated calcium channel, which are found in most people with LEMS. A positive result supports the diagnosis but is not enough on its own. Nerve conduction testing measures how strongly muscles respond to small electrical pulses. In LEMS the response is low at rest and increases sharply after about 10 seconds of exercise or rapid stimulation, a pattern that points to a problem at the nerve ending. Because of the strong link with lung cancer, a LEMS diagnosis is followed by a careful search for cancer, usually with a computed tomography (CT) scan of the chest and sometimes a positron emission tomography (PET) scan, which highlights unusually active tissue. If nothing is found, screening is typically repeated over the following years, since the cancer can appear after the LEMS does. How long and how often depends on age, smoking history and other risk factors.

Treatment Options

Treatment has three parts: treating any cancer, easing symptoms and, when needed, calming the immune attack. When LEMS is linked to small cell lung cancer, treating the cancer comes first and can improve or occasionally resolve the weakness. Amifampridine (Firdapse) is the first-choice medicine for symptoms. It blocks potassium channels on the nerve endings, which keeps them active longer so more acetylcholine is released. In randomized trials it improved muscle strength. It is approved for adults and children 6 and older. Tingling sensations and stomach upset are common side effects. It can cause seizures in a small number of people, so it is not used in anyone with a history of seizures, and the doctor will review other medicines that could raise seizure risk. Pyridostigmine (Mestinon), a medicine more often used for myasthenia gravis, is sometimes added, though its benefit in LEMS is limited. If weakness remains troublesome, immune treatments may be used. These include prednisone (a steroid) or azathioprine, which suppress the immune system, and intravenous immunoglobulin (IVIg), donated antibodies given by infusion, the immune treatment with the clearest trial evidence in LEMS. Plasma exchange, which filters antibodies out of the blood, and rituximab are options for severe or stubborn cases. Immune-suppressing drugs have side effects of their own that need monitoring, so their use is weighed against how much the weakness limits daily life.

What to Expect

Without an underlying cancer, LEMS does not shorten life expectancy, but it is usually long-lasting and complete remission is uncommon. Most people improve with treatment and adjust doses over time with a neurologist, aiming for the best function with the fewest side effects. Strength can fluctuate, so some days are harder than others. When LEMS is linked to cancer, the outlook depends mainly on the cancer. People with small cell lung cancer and LEMS tend to fare better than those with the same cancer and no LEMS. One practical point matters for life: people with LEMS are very sensitive to the muscle-relaxing drugs used during general anesthesia, which can cause prolonged weakness or breathing problems after surgery. Telling every surgeon, dentist and anesthesia team about the diagnosis before any procedure allows them to plan safely.

When to Seek Help

See a doctor if you notice weakness in your hips or thighs that gradually makes stairs, standing up or walking harder, especially with dry mouth or a history of smoking. If you already have LEMS, contact your care team promptly if weakness is clearly worsening, new problems with swallowing or speech develop, or you have a seizure while taking amifampridine. Trouble breathing, or swallowing so weak that you cannot clear food or saliva, needs emergency care.

Questions to Ask Your Doctor

  1. 1.Is my LEMS likely to be linked to cancer, and what screening will I need and for how long?
  2. 2.What can amifampridine realistically improve for me, and how will we adjust the dose?
  3. 3.When would immune treatment make sense, and what are the trade-offs for me?
  4. 4.Which medicines should I avoid or check with you first, and what should I tell a surgical team?
  5. 5.How will we measure whether my strength is improving over time?

Last reviewed • Oct 2026

Educational content, not medical advice.